O’Regan, S.; O’Kelly, B.; Reidy, P.; O’Toole, A.; Caird, J.; McNally, C.; McConkey, S.; De Barra, E.
Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis. J. Fungi 2022, 8, 557.
https://doi.org/10.3390/jof8060557
AMA Style
O’Regan S, O’Kelly B, Reidy P, O’Toole A, Caird J, McNally C, McConkey S, De Barra E.
Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis. Journal of Fungi. 2022; 8(6):557.
https://doi.org/10.3390/jof8060557
Chicago/Turabian Style
O’Regan, Siobhan, Brendan O’Kelly, Paul Reidy, Aoibhlinn O’Toole, John Caird, Cora McNally, Samuel McConkey, and Eoghan De Barra.
2022. "Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis" Journal of Fungi 8, no. 6: 557.
https://doi.org/10.3390/jof8060557
APA Style
O’Regan, S., O’Kelly, B., Reidy, P., O’Toole, A., Caird, J., McNally, C., McConkey, S., & De Barra, E.
(2022). Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis. Journal of Fungi, 8(6), 557.
https://doi.org/10.3390/jof8060557
